000 | 01562 a2200457 4500 | ||
---|---|---|---|
005 | 20250513193815.0 | ||
264 | 0 | _c19991223 | |
008 | 199912s 0 0 eng d | ||
022 | _a1468-201X | ||
024 | 7 |
_a10.1136/hrt.82.5.589 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMacdonald, P S | |
245 | 0 | 0 |
_aImpact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure. _h[electronic resource] |
260 |
_bHeart (British Cardiac Society) _cNov 1999 |
||
300 |
_a589-93 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aAmiodarone _xadverse effects |
650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xtherapeutic use |
650 | 0 | 4 |
_aCarbazoles _xadverse effects |
650 | 0 | 4 | _aCarvedilol |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPropanolamines _xadverse effects |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aVentricular Remodeling _xdrug effects |
700 | 1 | _aKeogh, A M | |
700 | 1 | _aAboyoun, C | |
700 | 1 | _aLund, M | |
700 | 1 | _aAmor, R | |
700 | 1 | _aMcCaffrey, D | |
773 | 0 |
_tHeart (British Cardiac Society) _gvol. 82 _gno. 5 _gp. 589-93 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/hrt.82.5.589 _zAvailable from publisher's website |
999 |
_c10482495 _d10482495 |